AFC-HD AMS Life Science Co., Ltd. provided earnings guidance for the year ending August 2023. For the period, the company expects net sales of ¥24,741 million, Operating profit of ¥1,481 million, and Profit attributable to owners of the parent of ¥687 million or ¥48.82 basic per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
871 JPY | -1.25% | +2.83% | +8.88% |
1st Jan change | Capi. | |
---|---|---|
+8.88% | 78.93M | |
+17.57% | 8.47B | |
+3.37% | 7.6B | |
+5.65% | 6.26B | |
-4.57% | 3.78B | |
-6.87% | 3.73B | |
-2.14% | 1.35B | |
-26.41% | 1.12B | |
+15.61% | 998M | |
-7.15% | 948M |
- Stock Market
- Equities
- 2927 Stock
- News AFC-HD AMS Life Science Co., Ltd.
- AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Year Ending August 2023